comparemela.com

Latest Breaking News On - Late breaking clinical research - Page 1 : comparemela.com

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery disease

United statesComunidad autonoma de catalunaGonzalez quesadaJamesp earlsEuropean association of cardiovascular imagingDrug administrationLate breaking clinical researchAmerican medical associationChief medical officerAmerican collegeCardiology annual scientific meeting new orleansPrognostic assessmentBased algorithmCoronary ischemiaEuropean associationCardiovascular imaging

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.

United statesComunidad autonoma de catalunaJamesp earlsJames earlsGonzalez quesadaUdo hoffmanSociety of cardiovascular computed tomographyEuropean heart journal cv imagRadiology at george washington universityLate breaking clinical researchAmerican society of cardiac imagingCleerly incFellows of the society cardiovascularEuropean association of cardiovascular imagingEuropean heart journal cardiovascularDiagnostic certainty

Supira Medical s Percutaneous Ventricular Assist Device (pVAD) to be Highlighted During PCR Innovator s Day and SCAI 2023

/PRNewswire/ Supira Medical, Inc., a Shifamed portfolio company, announced today that its next generation percutaneous ventricular assist device (pVAD) was.

France generalUnited statesNitin salunkeGagan singhKatie arnoldAmr salahiehSupira medical incSociety for cardiovascular angiographyEuropean association of percutaneous cardiovascular interventionsPrnewswire supira medical incClinical cardiovascular research at university of californiaFirst floor of the phoenix convention centerClinical research sessionClinical researchLate breaking clinical research sessionEuropean association

Supira Medical, Inc : Supira Medical s Percutaneous Ventricular Assist Device (pVAD) to be Highlighted During PCR Innovator s Day and SCAI 2023

Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic

United statesFrance generalNitin salunkeKatie arnoldGagan singhAmr salahiehFirst floor of the phoenix convention centerClinical researchClinical cardiovascular research at university of californiaPrnewswire supira medical incClinical research sessionEuropean association of percutaneous cardiovascular interventionsSociety for cardiovascular angiographySupira medical incLate breaking clinical research sessionEuropean association

vimarsana © 2020. All Rights Reserved.